Evotec shares fall 1.43% intraday after Deutsche Bank reiterates Neutral rating.

Evotec Se declined 1.43% in intraday trading, with Deutsche Bank reiterating its Neutral rating and maintaining a target price of EUR 7. The bank's research also indicated a lack of expected improvement in the company's second-quarter report, forecasting a 4% revenue growth and a loss of EUR 2.8 million in adjusted EBITDA.